Through translational research that is a core part of our mission as a nonprofit academic medical center, the clinicians and scientists at Cedars-Sinai Medical Center work to accelerate the transfer of medical advances from bench to bedside with the goal of ensuring that patients across the globe are able to lead better and longer lives.
Cedars-Sinai’s Technology Transfer Office plays a crucial role in this process by helping bring new therapies and medical technology to the marketplace where they can have the greatest impact on society. Our “tech transfer” team manages an intellectual property portfolio of more than 200 technologies. The royalty income the Medical Center earns by licensing technology is reinvested back into our research program to generate a new cycle of discoveries that will eventually join the technology transfer pipeline.
Cedars-Sinai has been at the forefront of medical and scientific advancement for more than a century. The Medical Center is ranked in the top tier of non-university hospitals nationwide that receive competitive research funding from the National Institutes of Health. This is a sign of our longstanding commitment to the highest quality disease-oriented research.
More than 900 major research projects are now underway at Cedars-Sinai, where world-class researchers are developing new therapies for cancer, heart disease, digestive diseases and neurologic and metabolic disorders, among other conditions.
We are always seeking new partners who share our drive to speed up medical progress. Just one novel idea can help countless patients and it is crucial to map out the quickest route from discovery to healthcare delivery. This is the role of our Technology Transfer Office, which has the expertise to navigate the challenging journey for each innovation. There are many exciting discoveries at Cedars-Sinai that are making their way to the marketplace, with the goal of developing products and other technologies that serve to improve the healthcare world. The technology transfer program ranks in the top ten nationally and has brought in over $150 million in the past ten years in technology related licensing income.
Specific roles of the Technology Transfer Office at Cedars-Sinai are:
- Educate the research faculty about the importance of protecting discoveries made in the laboratories and the role that the Tech Transfer Office plays in the translational mission of the Research Institute,
- Identify potential candidates for the invention disclosure process by, for example, reviewing manuscripts or abstracts before any public disclosures concerning the research is made,
- Capture new technologies by encouraging the submission of Invention Disclosures to the Tech Transfer Office for assessment,
- Assess whether the invention or technology has potential market value to warrant the investment of resources into the patent protection process,
- Protect the new technology by determining whether the invention is a good candidate for patent protection or some other form of intellectual property protection,
- Market the technologies by identifying potential commercial partners to assist in the development, regulatory approval process and ultimate manufacture and distribution of the technology in the market place,
- Market the new inventions by determining whether a technology is a candidate for the creation of a “spin-off” company to focus on the further development of the invention,
- License the technology to a commercial partner or spin-off company, as the case may be,
- Enforce the rights of the Medical Center by monitoring potential infringing use of the technology in the marketplace by companies without an appropriate license,
- Share the royalty income with the inventors as required by the Bayh-Dole Act as institutionalized in the Medical Center’s policies and procedures,
- Monitor the relationships with the licensees of the Medical Center’s technologies to ensure that the inventions are being developed and brought through the regulatory process, and
- Report on these various activities to senior management, the inventors and to the other departments of the Medical Center as may be appropriate.